| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |